骨髓分裂性瘤的免疫生物学:一个迷你回顾

Shruthi Kannan1, Rolando A Vedia1, Jeffrey J Molldrem1,2,3

  • 1Department of Hematopoietic Biology and Malignancy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Frontiers in immunology
|October 2, 2024
PubMed
概括

本综述探讨了免疫系统功能障碍如何驱动骨髓质疏松综合征 (MDS) 和进展到急性骨髓性白血病 (AML). 它涵盖了当前和实验性疗法,突出了改善患者治疗结果的研究差距.